Therapeutic treatment for metabolic syndrome, type 2...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/495 (2006.01) A61K 31/13 (2006.01) A61K 31/16 (2006.01) A61K 31/4164 (2006.01) A61K 31/425 (2006.01) A61K 31/435 (2006.01) A61K 31/46 (2006.01) A61K 31/48 (2006.01) A61K 31/55 (2006.01) A61K 38/16 (2006.01) A61K 45/06 (2006.01) A61P 3/00 (2006.01)

Patent

CA 2688035

The present invention is directed to a method for treating a patient suffering from the metabolic syndrome, Type 2 diabetes, obesity, or prediabetes, comprising the step of increasing the ratio of dopaminergic neuronal to noradrenergic neuronal activity within the central nervous system and particularly the hypothalamus of the central nervous system of the patient.

La présente invention concerne un procédé permettant de traiter un patient souffrant du syndrome métabolique, du diabète de type 2, d'obésité, ou de prédiabète. Le procédé consiste à accroître le rapport de l'activité neuronale dopaminergique à l'activité neuronale noradrénergique dans le système nerveux central et, en particulier, l'hypothalamus du système nerveux central du patient.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Therapeutic treatment for metabolic syndrome, type 2... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Therapeutic treatment for metabolic syndrome, type 2..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic treatment for metabolic syndrome, type 2... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1892515

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.